Company news

01 March 2018

GC Alkor Bio won a grant from the Fund for the Promotion of Innovation within the framework of the VI stage of the competition "Commercialization"

On February 22, the results of the sixth stage of the competitive selection under the program "Commercialization" were approved by the protocol of the Directorate of the Foundation for Assistance to Small Innovative Enterprises (Fund for the Promotion of Innovations). The group of companies Alkor Bio with the project "Production and commercialization of test systems for infectious and hormonal diagnostics by the method of immunochemical analysis" became the winner of the competition and now, according to its conditions, will receive a grant of 15 million rubles for the commercialization of R & D results.

25 December 2017

Merry Christmas and Happy New Year!

25 December 2017

Alkor Bio Group finished the year by launching new 14 allergens

At the last weeks of the 2017 year Alkor Bio Group has launched 14 new allergens. For the present time Alkor Bio catalogue includes 739 allergens, allergen mixes and allergen components.

06 December 2017

Alkor Bio Group’s Microbiology laboratory has launched a new product: herpes simplex virus type 1 antigen (strain F)

In December 2017, Alkor Bio Group’s Microbiology laboratory has launched a new product: herpes simplex virus type 1 antigen (strain F). 

13 November 2017

Alkor Bio Group of Companies has transferred to the new versions of international QMS standards ISO 9001:2015 and ISO 13485:2016

On November, Alkor Bio Group of Companies, Russian developer and manufacturer of the test kits for ELISA and PCR diagnostic In Vitro, has been received the new certificates conforming compliance with the International standards ISO 9001 and ISO 13485, versions 2015 and 2016.

07 September 2017

GC Alkor Bio together with Saint-Petersburg Pasteur Institute received patent "Method for identifying variants A and B of human herpesvirus type 6"

In August Group of Companies Alkor Bio and Saint-Petersburg Pasteur Institute received a patent "Method for identifying variants A and B of human herpesvirus type 6". The patent RU 2627607 was issued by Russian Federal Service for Intellectual Property (Rospatent). The invention relates to the field of biotechnology, in particular, to the clinical laboratory diagnosis of viral infections and can be used for genotyping of herpesvirus type 6 (HHV-6). Fast and reliable method for identification and differentiation of HHV-6A and HHV-6B types was claimed.